Electrophysiology Devices Market to Witness a Healthy Growth by 2030

According to Precedence Research, during the forecast period of 2020 to 2027, the global electrophysiology devices market is estimated to develop at a compound annual growth rate (CAGR) of 8.6%. The global electrophysiology devices market was valued at USD 5.54 billion in 2019, and it is predicted to exceed USD 10.72 billion by 2027. The study investigates several elements and their consequences on the growth of the electrophysiology devices market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1100

Growth Factor

As the prevalence of cardiac arrhythmia is constantly increasing on the global level, electrophysiology devices accounted for substantial recognition in the forthcoming years. Distinctive modalities of electrophysiology devices that include cardiac magnetic resonance imaging (CMR), cardiac computerized tomography (CT), echocardiography, fluoroscopy, and electro-anatomic mapping; support healthcare professionals to prodigiously analyze the principal mechanisms of multiple cases of arrhythmia.

In addition, worldwide penetration of electrophysiology devices is likely to encounter a tectonic upshift by the year 2027 because of remarkable technological disruption in the healthcare industry. The strategic expansion plans of market participants remains aligned toward matured markets that are already consolidated by the significant presence of large companies. While matured markets will continue to provide substantial revenue-generating opportunities for aspiring brands in the global electrophysiology devices market, evolving markets are likely to promise alluring opportunities for these brands to increase their sales revenues.

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1100

This report focuses on electrophysiology devices market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall electrophysiology devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Report Highlights

• North America dominated the global market in the year 2019 owing to technological advancements in the healthcare industry along with favorable government support
• The Asia Pacific exhibits the fastest growth over the forecast period owing to significant presence of untapped opportunities in reference to unmet medical requirements along with rapid growth in the incidence rates of target diseases
• Atrial fibrillation leads the indication segment in the global electrophysiology devices market for the year 2019.
• Diagnostic devices application segment accounted for the largest value share in 2019 attributed to significant application of cardiac monitors as a standard monitoring and diagnostic tool for arrhythmias
• The electrophysiology treatment devices segment offers lucrative growth opportunity in the coming years. Pacemakers emerged as the largest sub-segment in the year 2019.
• Based on end-use, hospitals led the global market in 2019 owing to rising Adoption of technologically advanced cardiac rhythm management and electrophysiological procedure devices

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of electrophysiology devices, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of electrophysiology devices has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the electrophysiology devices market.

Some of the prominent players in the electrophysiology devices market include:

• Medtronic Plc
• Abbot Laboratories
• Boston Scientific Corporation
• Biotronik SE & CO. KG
• Biosense Webster, Inc.
• Nihon Kohden Corporation
• GE Healthcare
• Microport Scientific Corporation
• Siemens AG
• Koninklijke Philips N.V.

Segments Covered in the Report

By Indication

• Atrial Fibrillation (AF)
• Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
• Supraventricular Tachycardia
• Bradycardia
• Wolff-Parkinson-White Syndrome (WPW)
• Others

By Application

• Diagnostic Devices
  • Diagnostic Electrophysiology Catheters
  • Holter Monitoring Devices
  • EP Mapping & Imaging Systems
  • Electrocardiograph (ECG)
  • Insertable Cardiac Monitors (ICM)
  • Others
• Treatment Devices
  • Automated external defibrillators (AEDs)
  • Implantable Cardioverter Defibrillators (ICDs)
  • CRT-D
  • CRT-P
  • Catheters
  • Pacemakers
  • Others

By End-User

• Ambulatory Surgical Centers
• Hospitals
• Others

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Electrophysiology Devices Market, By Indication

7.1. Electrophysiology Devices Market, by Indication Type, 2020-2027
7.1.1. Atrial Fibrillation (AF)
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Atrioventricular Nodal Re-entry Tachycardia (AVNRT)
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Supraventricular Tachycardia
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Bradycardia
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Wolff-Parkinson-White Syndrome (WPW)
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Others
7.1.6.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global Electrophysiology Devices Market, By Application

8.1. Electrophysiology Devices Market, by Application, 2020-2027
8.1.1. Diagnostic Devices
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Treatment Devices
8.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Electrophysiology Devices Market, By End-User

9.1. Electrophysiology Devices Market, by End-User, 2020-2027
9.1.1. Ambulatory Surgical Centers
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Hospitals
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Electrophysiology Devices Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.3. Market Revenue and Forecast, by End-User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.1.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.2.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.3.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.6.3. Market Revenue and Forecast, by End-User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Indication (2016-2027)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2027)
10.4.7.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.4.3. Market Revenue and Forecast, by End-User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Indication (2016-2027)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2027)
10.5.5.3. Market Revenue and Forecast, by End-User (2016-2027)

Chapter 11. Company Profiles

11.1. Medtronic Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Abbot Laboratories
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Boston Scientific Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Biotronik SE & CO. KG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Biosense Webster, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Nihon Kohden Corporation
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. GE Healthcare
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Microport Scientific Corporation
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Siemens AG
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Koninklijke Philips N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1100

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com